For the past 12 years, LIDE (Lab for Innovated Diagnosis and Experimental Therapeutics) has partnered with small biotech companies and multinational pharmaceutical organizations and delivered thousands of projects successfully. LIDE has a global presence and pride itself on strong academic relationships.
MiniPDX
LIDE’s novel in vivo drug efficacy test is the in vivo version of organoid assay and takes only 7 days.
Read More >CR
LIDE has developed over 100 CR cells, some with special drug resistance/genetic alteration.
Read More >
K Cell & FGI
LIDE requires only a small sample to generate visual expression maps of cell functional subpopulations.
Read More >Pre-clinical Bio-marker Identification
LIDE’s Functional Diagnosis platform identifies biomarkers during the pre-clinical stage.
Read More >Immuno-Oncology Studies
One-stop shop to support an all-around biologics R&D in immunotherapy.
Read More >